Global Viral Vector Manufacturing Market shows the Industry Overview with Definition, Product Development History. This is an in-depth research which shows the world’s main region industry conditions and forecasts 2023.
—
The viral vector manufacturing market is expected to reach USD 815.8 million by 2023 from an estimated USD 327.8 million in 2018, at a CAGR of 20.0%. The growth of this market is expected to be driven by rising prevalence of target diseases and disorders, the availability of funding for gene therapy development, effectiveness of viral vectors in gene therapy delivery, and ongoing research into viral vector-based gene & cell therapies.
Download Sample Report @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=1607205 .
Viral Vector Manufacturing Market, By Disease
1 Introduction
2 Cancer
3 Genetic Disorders
4 Infectious Diseases
Viral Vector Manufacturing Market, By Application
1 Introduction
2 Gene Therapy
3 Vaccinology
The growth of this market is expected to be driven by rising prevalence of target diseases and disorders, the availability of funding for gene therapy development, effectiveness of viral vectors in gene therapy delivery, and ongoing research into viral vector-based gene & cell therapies.
North America is expected to account for the largest share of 64.8% of the global viral vector manufacturing market. Factors such as a large number of regenerative medicine companies (including gene and cell therapy companies), increasing research activities, rising prevalence of target diseases, and availability of funding are supporting the growth of the viral vector manufacturing market in North America.
Break of primary participants was as mentioned below:
• By Company Type – Tier 1–40%, Tier 2–30% and Tier 3–30%
• By Designation – C-level–20%, Director Level–40%, Others–40%
• By Region – North America–50%, Europe–20%, Asia Pacific–20%, RoW–10%
The major players in the global market are Lonza (Switzerland), Merck (Germany), Oxford BioMedica (UK), CGT Catapult (UK), Cobra Biologics (UK), uniQure (Netherlands), FUJIFILM Diosynth Biotechnologies (US), and Spark Therapeutics (US).
Direct Order this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=1607205 .
The report will help established firms as well as new entrants/smaller firms gauge the pulse of the market, which in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their position in the market.
Target Audience
1 Pharmaceutical and biotechnology companies
2 Viral vector developers
3 Contract development and manufacturing organizations (CDMOs)
4 Business research and consulting firms
5 Research institutions
6 Venture capitalists
The report analyzes the viral vector manufacturing market and aims at estimating the market size and future growth potential of this market based on various aspects such as type, disease, application, end user, and region. The report also includes the competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.
List of Tables
1 Approved Viral Vector Gene Therapies
2 Number of Clinical Trials Registered on Various Viral Vectors Globally
3 Viral Vector Manufacturing Market, By Type, 2016–2023 (USD Million)
4 Viral Vector Manufacturing Market for Retroviral Vectors, By Type, 2016–2023 (USD Million)
5 Viral Vector Manufacturing Market for Retroviral Vectors, By Region, 2016–2023 (USD Million)
6 Viral Vector Manufacturing Market for Lentiviral Vectors, By Region, 2016–2023 (USD Million)
7 Viral Vector Manufacturing Market for Gamma-Retroviral Vectors, By Region, 2016–2023 (USD Million)
8 Viral Vector Manufacturing Market for Adenoviral Vectors, By Region, 2016–2023 (USD Million)
9 Viral Vector Manufacturing Market for Adeno-Associated Viral Vectors, By Region, 2016–2023 (USD Million)
10 Gene Therapy Applications of Other Viral Vectors
Contact Info:
Name: Hrishikesh Patwardhan
Email: sales@rnrmarketresearch.com
Organization: RnRMarketResearch
Phone: +1 888 391 5441
For more information, please visit http://www.rnrmarketresearch.com/viral-vector-manufacturing-market-by-type-retrovirus-gammaretrovirus-aav-disease-cancer-infectious-disease-genetic-disorders-application-gene-therapy-vaccinology-end-user-biotech-companies-research-i-st-to-2023-market-report.html
Source: MarketersMedia
Release ID: 423006
